CN Stock MarketDetailed Quotes

Tianjin Chase Sun Pharmaceutical (300026)

Watchlist
  • 3.60
  • +0.01+0.28%
Market Closed Mar 13 15:00 CST
10.81BMarket Cap-163.64P/E (TTM)

Tianjin Chase Sun Pharmaceutical (300026) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Prescription granules and tablets of traditional Chinese Medicine1.23B44.07%
Total special adjustments644.31M23.05%
Xuebijing injection467.29M16.72%
药械智慧供应链433.16M15.50%
Other business18.57M0.66%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Drugs1.93B68.91%
智慧供应链433.16M15.50%
Raw and auxiliary materials213.92M7.65%
medical apparatus179.85M6.43%
Other42.14M1.51%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
East China region839.78M30.05%
North China735.7M26.32%
Central China411.22M14.71%
overseas market216.5M7.75%
Southwest area201.58M7.21%
South China150.84M5.40%
Northwest region121.93M4.36%
Northeast area117.43M4.20%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More